Principal Financial Group Inc Mustang Bio, Inc. Transaction History

Principal Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.58 - $1.13 $5,949 - $11,590	-10,257 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$0.73 - $1.81 $421 - $1,046	-578 Reduced 5.33%	10,257 $10,000
Q4 2021 Feb 09, 2022	SELL	$1.66 - $2.64 $3,246 - $5,163	-1,956 Reduced 15.29%	10,835 $18,000
Q3 2021 Nov 09, 2021	SELL	$2.58 - $3.36 $5,353 - $6,972	-2,075 Reduced 13.96%	12,791 $34,000
Q2 2021 Aug 10, 2021	BUY	$2.7 - $3.81 $10,395 - $14,668	3,850 Added 34.95%	14,866 $49,000

Q1 2021 May 10, 2021	SELL	$3.02 - $5.16 $5,242 - $8,957	-1,736 Reduced 13.61%	11,016 $37,000
Q4 2020 Feb 08, 2021	BUY	$2.66 - $4.18 $33,920 - $53,303	12,752 New	12,752 $48,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $35.8M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.